Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
7.89
+0.30 (3.95%)
At close: Mar 10, 2026, 4:00 PM EDT
7.86
-0.03 (-0.38%)
After-hours: Mar 10, 2026, 6:38 PM EDT

Fennec Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
21.9526.6313.2723.7721.130.34
Cash & Short-Term Investments
21.9526.6313.2723.7721.130.34
Cash Growth
-45.57%100.72%-44.19%12.67%-30.46%122.30%
Accounts Receivable
19.3412.888.811.55--
Inventory
2.481.062.160.58--
Other Current Assets
2.33.552.620.831.291.07
Total Current Assets
46.0644.1226.8626.7322.3931.42
Other Long-Term Assets
3.20.820.010.810.03-
Total Assets
49.2644.9526.8626.9422.4131.42
Accounts Payable
5.873.243.782.390.781.57
Accrued Expenses
3.73.433.752.220.880.78
Current Portion of Leases
0.2500.02---
Unearned Revenue
-0.25----
Total Current Liabilities
9.826.927.554.611.652.35
Long-Term Debt
19.3819.3430.9324.94.99-
Other Long-Term Liabilities
24.5624.560---
Total Long-Term Liabilities
43.9443.930.9324.94.99-
Total Liabilities
53.7550.8238.4929.516.642.35
Common Stock
147.65145.61144.31142.59140.8140.73
Additional Paid-in Capital
71.2566.9662.0756.853.2149.23
Accumulated Other Comprehensive Income
1.241.241.24-1.241.24
Retained Earnings
-224.64-219.68-219.25-203.2-179.49-162.14
Shareholders' Equity
-4.49-5.87-11.62-2.5715.7729.07
Total Liabilities & Equity
49.2644.9526.8626.9422.4131.42
Total Debt
19.6319.3430.9524.94.990
Net Cash (Debt)
2.327.29-17.68-1.1316.1130.34
Net Cash Growth
-68.17%----46.90%122.30%
Net Cash Per Share
0.080.27-0.67-0.040.621.28
Book Value
-4.49-5.87-11.62-2.5715.7729.07
Book Value Per Share
-0.16-0.22-0.44-0.100.611.23
Tangible Book Value
-4.49-5.87-11.62-2.5715.7729.07
Tangible Book Value Per Share
-0.16-0.22-0.44-0.100.611.23
Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q